Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Infectious Disease

Standard of Care Treatment

At a Glance

The primary treatment for Babesiosis is a 7-10 day course of atovaquone and azithromycin. Severe cases may require clindamycin and quinine or a red blood cell exchange transfusion. Because it is a parasitic infection, standard Lyme disease antibiotics like doxycycline are not effective.

Treating Babesiosis requires a strategic approach. Because it is caused by a parasite, standard antibiotics used for Lyme disease (like doxycycline) are not effective [1]. Instead, doctors follow guidelines from the Infectious Diseases Society of America (IDSA) to choose specific anti-parasitic medications based on the severity of your illness and the health of your immune system [2].

Standard Medication Regimens

Most patients are treated with one of two primary drug combinations. The choice depends on how sick you are and how well you can tolerate certain side effects.

1. First-Line Treatment: Atovaquone + Azithromycin

This is the standard of care for mild-to-moderate cases [3].

  • Why it’s used: It is generally very effective and much better tolerated than older treatments, with fewer side effects [4].
  • Duration: A typical treatment course lasts 7 to 10 days for most healthy people [3][2]. Your doctor will determine the exact daily dose based on current clinical guidelines.

2. Alternative/Severe Treatment: Clindamycin + Quinine

This combination is typically reserved for severe cases or patients who do not respond to first-line therapy [3].

  • Why it’s used: It is highly potent, but it is much more likely to cause side effects like ringing in the ears (tinnitus), hearing loss, vertigo, and intense stomach upset [4][5].
  • Administration: In severe cases, the clindamycin may be given through an IV in the hospital [6].

When Advanced Intervention is Needed

In extremely severe cases, medications alone may not work fast enough to save the remaining healthy red blood cells. In these instances, a specialized procedure called Red Blood Cell (RBC) Exchange Transfusion (erythrocytapheresis) may be necessary [7].

This procedure is high-risk and is generally reserved for extreme cases. A doctor will typically consider an exchange transfusion if you have:

  • Dangerously High Parasitemia: Your parasite count is exceptionally high (often 10% or greater) [8][9].
  • Severe Anemia and Organ Failure: A drop in hemoglobin levels on its own is usually not enough to warrant this procedure. It is considered when severe anemia occurs simultaneously with signs of acute organ failure, such as severe lung or kidney dysfunction [7][4].

This procedure works by physically removing the infected red blood cells and replacing them with healthy donor cells, rapidly reducing the “parasite burden” in your body [7][8].

Challenges with Drug Resistance

While most cases clear up quickly, some parasites can develop antimicrobial resistance [10]. This is most common in patients with weakened immune systems who have to take the medications for a long time [10].

  • Genetic Mutations: Scientists have found specific mutations, such as in the cytochrome b gene, that make the parasite “immune” to atovaquone [10].
  • Extended Treatment: If you are at high risk, your doctor may extend your treatment significantly to ensure every last parasite is gone [10][2]. (See High-Risk Populations).

Common questions in this guide

Why can't I just use doxycycline for Babesiosis like I do for Lyme disease?
Because Babesiosis is caused by a parasite, not bacteria, standard antibiotics used for Lyme disease are not effective. Instead, doctors must use specific anti-parasitic medications to clear the infection.
What are the standard medications used to treat Babesiosis?
The standard first-line treatment for most mild-to-moderate Babesiosis cases is a combination of atovaquone and azithromycin. This regimen typically lasts 7 to 10 days and is generally well-tolerated by patients.
What treatments are used if my Babesiosis infection is severe?
Severe cases are typically treated with a highly potent combination of clindamycin and quinine, which may be administered intravenously in a hospital. This regimen is more likely to cause side effects like ringing in the ears and stomach upset.
What is a red blood cell exchange transfusion for Babesiosis?
This is a specialized procedure reserved for extreme cases with dangerously high parasite levels or organ failure. It works by physically removing infected red blood cells from your body and replacing them with healthy donor cells.
How long does treatment for Babesiosis usually last?
A standard treatment course lasts 7 to 10 days for healthy individuals. However, immunocompromised patients or those with drug-resistant parasites may need a significantly extended treatment plan to ensure every parasite is gone.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on the severity of my symptoms, should I be on the Atovaquone/Azithromycin regimen or the Clindamycin/Quinine regimen?
  2. 2.Am I considered 'high risk' or immunocompromised, and if so, should my treatment last longer than 10 days?
  3. 3.Does my current parasitemia level (parasite percentage) put me at risk for needing a red blood cell exchange transfusion?
  4. 4.If I don't respond to the first-line drugs, will you test for specific genetic mutations (like cytochrome b) that cause drug resistance?
  5. 5.What are the most common side effects I should watch for with these medications, especially if we use Quinine?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (10)
  1. 1

    Superior real-time polymerase chain reaction detection of Babesia microti parasites in whole blood utilizing high-copy BMN antigens as amplification targets.

    Grabias B, Clement J, Krause PJ, et al.

    Transfusion 2018; (58(8)):1924-1932 doi:10.1111/trf.14642.

    PMID: 29664114
  2. 2

    Management strategies for human babesiosis.

    Smith RP, Hunfeld KP, Krause PJ

    Expert review of anti-infective therapy 2020; (18(7)):625-636 doi:10.1080/14787210.2020.1752193.

    PMID: 32268823
  3. 3

    A Five-Week-Old Twin With Profound Anemia: A Case Report of Asymmetric Congenital Babesiosis.

    Walker S, Coray E, Ginsberg-Peltz J, Smith L

    Cureus 2022; (14(3)):e22774 doi:10.7759/cureus.22774.

    PMID: 35382190
  4. 4

    Babesiosis: Appreciating the Pathophysiology and Diverse Sequela of the Infection.

    Ortiz JF, Millhouse PW, Morillo Cox Á, et al.

    Cureus 2020; (12(10)):e11085 doi:10.7759/cureus.11085.

    PMID: 33224678
  5. 5

    Risk Factors for Severe Infection, Hospitalization, and Prolonged Antimicrobial Therapy in Patients with Babesiosis.

    Mareedu N, Schotthoefer AM, Tompkins J, et al.

    The American journal of tropical medicine and hygiene 2017; (97(4)):1218-1225 doi:10.4269/ajtmh.17-0146.

    PMID: 28722598
  6. 6

    Trust the Process: Prolonged Babesia Parasitemia in an Elderly Man with Asplenia from the American Midwest.

    Ivancich M, Lutwick L, Shweta FNU

    The American journal of case reports 2022; (23()):e936326 doi:10.12659/AJCR.936326.

    PMID: 35844076
  7. 7

    Apheresis for babesiosis: Therapeutic parasite reduction or removal of harmful toxins or both?

    Saifee NH, Krause PJ, Wu Y

    Journal of clinical apheresis 2016; (31(5)):454-8 doi:10.1002/jca.21429.

    PMID: 26481763
  8. 8

    Repeat exchange transfusion for treatment of severe babesiosis.

    Radcliffe C, Krause PJ, Grant M

    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2019; (58(5)):638-640 doi:10.1016/j.transci.2019.07.010.

    PMID: 31526674
  9. 9

    Severe Babesiosis With Heavy Parasitemia in an Immunocompetent Patient Treated Successfully With Red Cell Exchange Transfusion.

    Sanivarapu RR, Kashyap V, Iqbal J

    Cureus 2022; (14(3)):e23344 doi:10.7759/cureus.23344.

    PMID: 35475076
  10. 10

    Broad Antimicrobial Resistance in a Case of Relapsing Babesiosis Successfully Treated With Tafenoquine.

    Rogers R, Krause PJ, Norris AM, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2023; (76(4)):741-744 doi:10.1093/cid/ciac473.

    PMID: 35684960

This page provides educational information about standard Babesiosis treatments. Always consult your infectious disease specialist or healthcare provider regarding specific medication regimens and dosages.

Get notified when new evidence is published on Babesiosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.